Joe Copia's daytrades/investments and thoughts Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Joe Copia's daytrades/investments and thoughts

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Instock who wrote (11892)	2/16/1999 9:07:00 AM
From: Joe Copia	Read Replies (2) of 25711

NEWS ALERT: CYGS ( LT HOLD ) Universities to Begin Studies With ssDNA Expression Vector HOUSTON--(BUSINESS WIRE)--Feb. 16, 1999--Cryogenic Solutions (OTC BB:CYGS) announced today that it will begin shipping, at cost, kits of the patented ssDNA intracellular expression vector to scientists at university research facilities. The kits are scheduled to be in the laboratories in the first week of March, 1999. CYGS holds the exclusive rights to the ssDNA expression vector under license from InGene Inc. Researchers at 19 universities, each trying to antisense a different gene, have requested the kits. All have experienced the common problem of inserting specific intact oligonucleotides into living cells in sufficient quantities to isolate the function of a gene of interest. "The ssDNA expression vector is the most promising technology yet developed to overcome the 'delivery' hurdle that stands between genetic research in the labs and an effective antisense gene therapy in living organisms," said CYGS Financial V.P., Lawrence Wunderlich. "The word 'delivery' is somewhat a misnomer. Once our vector is transfected it actually synthesizes single strands of the programmed DNA sequence inside the cell." The ssDNA vector kits will be provided to university investigators at cost for non-commercial use only. The agreement under which the vector material will be transferred to the universities will facilitate CYGS's documentation of the efficacy of the combined vector and anti-sense technologies. CONTACT: Cryogenic Solutions, Houston Dell Gibson, 713/780-1399

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next